- Trials with a EudraCT protocol (26)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (11)
26 result(s) found for: Anticonvulsant.
Displaying page 1 of 2.
EudraCT Number: 2016-002177-35 | Sponsor Protocol Number: GNB-2015 | Start Date*: 2018-05-07 |
Sponsor Name:Masarykova univerzita | ||
Full Title: The effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma | ||
Medical condition: Chronic neuropathic pain in patients after spinal cord trauma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000565-37 | Sponsor Protocol Number: RD-5103-003-07 | Start Date*: 2007-09-17 | |||||||||||
Sponsor Name:University of Nottingham | |||||||||||||
Full Title: A Prospective Study to Determine the Adverse Drug Reactions Profile of Anticonvulsants in Children | |||||||||||||
Medical condition: Childhood epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002188-13 | Sponsor Protocol Number: UoL001087 | Start Date*: 2015-03-03 | |||||||||||
Sponsor Name:University of Liverpool [...] | |||||||||||||
Full Title: Emergency Treatment with Levetiracetam or Phenytoin in Status Epilepticus in Children (EcLiPSE) – an open label randomised controlled trial | |||||||||||||
Medical condition: Convulsive Status Epilepticus | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000869-11 | Sponsor Protocol Number: NC200601 | Start Date*: 2006-12-20 | |||||||||||
Sponsor Name:Neuro-Consil GmbH | |||||||||||||
Full Title: Comparison of efficacy and tolerability of rapid intravenous infusion of levetiracetam and sodium valproat. | |||||||||||||
Medical condition: Focal epilepsy requiring rapid initiation of anticonvulsant protection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001338-33 | Sponsor Protocol Number: TOPMAT-PEP-3001 | Start Date*: 2006-01-20 |
Sponsor Name:Janssen-Cilag International N.V. | ||
Full Title: A Randomized, Double-Blind, Placebo Controlled, Fixed Dose-Ranging Study to Assess the Safety, Tolerability, and Efficacy of Topiramate Oral Liquid and Sprinkle Formulations as an Adjunct to Concur... | ||
Medical condition: Partial Onset Epilepsy and other Seizures | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) FI (Prematurely Ended) HU (Prematurely Ended) CZ (Prematurely Ended) ES (Completed) NO (Ongoing) BE (Completed) IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-002055-15 | Sponsor Protocol Number: J81J1100168007 | Start Date*: 2014-01-28 |
Sponsor Name:UNIVERSITY OF SASSARI | ||
Full Title: RANDOMIZED, CONTROLLED, MULTI-CENTER, INTERNATIONAL CLINICAL STUDY ON THE MOOD-STABILIZING EFFECTS OF MEMANTINE AS AN AUGMENTING AGENT vs. LAMOTRIGINE FOR ONGOING TREATMENT IN BIPOLAR-I DISORDER P... | ||
Medical condition: BIPOLAR I MOOD DISORDERS | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003193-10 | Sponsor Protocol Number: CDKO-125a-002 | Start Date*: 2009-02-24 | ||||||||||||||||
Sponsor Name:Nerviano Medical Sciences S.r.l. | ||||||||||||||||||
Full Title: A phase I/II study of oral PHA-848125AC given daily for 14 consecutive days every 3 weeks in recurrent malignant glioma | ||||||||||||||||||
Medical condition: Phase I Part: Recurrent Malignant Glioma Phase II Part: Recurrent Glioblastoma Multiforme | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-004463-37 | Sponsor Protocol Number: 140682 | Start Date*: 2016-06-20 |
Sponsor Name:St. Olavs Hospital | ||
Full Title: ACUTE AND LONG-TERM EFFECTS OF INTRANASAL OXYTOCIN IN ALCOHOL WITHDRAWAL AND DEPENDENCE: A PROSPECTIVE RANDOMIZED PARALLEL GROUP PLACEBO-CONTROLLED TRIAL | ||
Medical condition: alcohol withdrawal and craving. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000875-33 | Sponsor Protocol Number: PLATA | Start Date*: 2013-08-27 | |||||||||||
Sponsor Name:Academic Medical Center, University of Amsterdam | |||||||||||||
Full Title: Prevention of Phantom Limb Pain After Transtibial Amputation (PLATA) - Randomized, double-blind, controlled, multi-center trial comparing Optimized intravenous pain control vs Optimized intravenous... | |||||||||||||
Medical condition: Phantom limb pain following amputation of the lower leg due to critical limb ischemia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) ES (Ongoing) AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005048-46 | Sponsor Protocol Number: D9673C00007 | Start Date*: 2021-06-02 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: An Open-Label, Multinational, Multicenter, Phase 3b/4 Study of Trastuzumab Deruxtecan in Patients With or Without Baseline Brain Metastasis With Previously-Treated Advanced/Metastatic HER2-Positive... | |||||||||||||
Medical condition: Treatment of patients with HER2-positive breast cancer with or without brain metastasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) IE (Ongoing) SE (Completed) NO (Completed) BE (Ongoing) DK (Ongoing) IT (Ongoing) PT (Ongoing) PL (Ongoing) FI (Completed) NL (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000942-21 | Sponsor Protocol Number: AIMS-2-CT1 | Start Date*: 2019-07-24 | |||||||||||||||||||||
Sponsor Name:Celso Arango | |||||||||||||||||||||||
Full Title: A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents w... | |||||||||||||||||||||||
Medical condition: Autism Spectrum Disorder | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002600-41 | Sponsor Protocol Number: CSTI571H2201 | Start Date*: 2006-01-17 |
Sponsor Name:Novartis Farmacéutica, S.A. | ||
Full Title: Estudio fase II, abierto, multicéntrico, no comparativo, que evalúa la eficacia de Glivec® con Hidroxiurea en pacientes con Glioblastoma Multiforme (GBM) en progresión, que no reciben fármacos anti... | ||
Medical condition: Glioblastoma multiforme progresivo (GBM) tras fallo a terapia de primera línea definida por cirugía, radioterapia y exposición a un régimen de quimioterapia de Temozolamida (TMZ). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) BE (Completed) SE (Completed) DE (Completed) DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-001645-26 | Sponsor Protocol Number: TMZ-FTM.CB.1 | Start Date*: 2008-06-01 | |||||||||||
Sponsor Name:ISTITUTO NEUROLOGICO "CARLO BESTA" | |||||||||||||
Full Title: Phase II study: Systemic treatment with alternating weekly regimen of temozolomide and monthly fotemustine combination in recurrent glioblastoma patients. | |||||||||||||
Medical condition: Glioblastoma recurrent | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002603-16 | Sponsor Protocol Number: CSTI571H2202 | Start Date*: 2006-01-17 |
Sponsor Name:Novartis Farmacéutica, S.A. | ||
Full Title: Estudio fase II, abierto, multicéntrico, no comparativo, que evalúa la eficacia de Glivec® con Hidroxiurea en pacientes con Glioblastoma Multiforme (GBM) en progresión, que reciben fármacos anticon... | ||
Medical condition: Glioblastoma multiforme progresivo (GBM) tras fallo a terapia de primera línea definida por cirugía, radioterapia y exposición a un régimen de quimioterapia de Temozolamida (TMZ). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) BE (Completed) SE (Completed) DE (Completed) DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-001278-26 | Sponsor Protocol Number: VEG102857 | Start Date*: 2006-10-31 |
Sponsor Name:GlaxoSmithKline Research & Development Limited | ||
Full Title: Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma | ||
Medical condition: Relaped Malignant Glioma = patients with anaplastic astrocytoma, anaplastic oligodendroglioma, mixed anaplastic oligoastrocytoma, glioblastoma multiforme or gliosarcoma at recurrence | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-003905-15 | Sponsor Protocol Number: GLITEM08 | Start Date*: 2008-07-29 | |||||||||||
Sponsor Name:ISTITUTO NEUROLOGICO "CARLO BESTA" | |||||||||||||
Full Title: Carmustine implant (Gliadel Wafer) plus adjuvant and concomitant Temozolomide in combination with radiotherapy in primary glioblastoma patients. | |||||||||||||
Medical condition: glioblastoma recurrent | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021163-33 | Sponsor Protocol Number: CCR3448 | Start Date*: 2011-03-08 | ||||||||||||||||
Sponsor Name:The Institute of Cancer Research [...] | ||||||||||||||||||
Full Title: A Phase II Trial of Cediranib in the Treatment of Patients with Alveolar Soft Part Sarcoma (CASPS). | ||||||||||||||||||
Medical condition: Alveolar Soft Part Sarcoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005088-82 | Sponsor Protocol Number: CAFQ056A2204 | Start Date*: 2008-05-15 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multi-centre, randomized, double-blind, placebo-controlled, two-period, crossover proof-of-concept study in patients with Fragile X Syndrome to assess the efficacy, safety and tolerability of mul... | |||||||||||||
Medical condition: Fragile X Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004478-41 | Sponsor Protocol Number: LCC001 | Start Date*: 2015-03-10 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Phase III trial in IntrahepaTic CHolestasis of pregnancy (ICP) to Evaluate urSodeoxycholic acid (UDCA) in improving perinatal outcomes | |||||||||||||
Medical condition: Intrahepatic Cholestasis of pregnancy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019268-35 | Sponsor Protocol Number: SP1007 | Start Date*: 2010-05-07 | |||||||||||
Sponsor Name:UCB Pharma SA | |||||||||||||
Full Title: A MULTI-CENTER, OPEN-LABEL STUDY TO EVALUATE THE TOLERABILITY, SAFETY AND EFFICACY OF LACOSAMIDE (200 mg - 400mg/day) AS ADD-ON THERAPY FOR PATIENTS WITH PARTIAL ONSET EPILEPSY USING A FLEXIBLE DOS... | |||||||||||||
Medical condition: Partial onset epilepsy with or without generalization | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.